C TAZ INJECTION 1000 MG/125 MG
By C Taz
Rx
10ml Injection in a Vial

Composition
Ceftriaxone(1000mg) + Tazobactum(125mg)

Manufacturer - Emcure Pharmaceuticals Ltd
255/2, Hinjawadi, Pune - 411057, India

Expires on or after
September, 2025

liver
When using C TAZ INJECTION 1000 MG/125 MG, it's important to be cautious if you have severe liver disease. In such cases, the dosage of C TAZ INJECTION 1000 MG/125 MG may need to be adjusted. It's crucial to consult your doctor before starting treatment with C TAZ INJECTION 1000 MG/125 MG if you have severe liver disease. However, if you have mild to moderate liver disease, dose adjustment of C TAZ INJECTION 1000 MG/125 MG is not typically recommended. Always follow your doctor's guidance and advice regarding the use of C TAZ INJECTION 1000 MG/125 MG in relation to your liver health.

kidney
Limited data exists on the use of C TAZ INJECTION 1000 MG/125 MG in people with kidney issues. It's recommended to seek advice from your doctor.

alcohol
When taking C TAZ INJECTION 1000 MG/125 MG, it is safe to consume alcohol as it does not lead to any harmful effects.

driving
C TAZ INJECTION 1000 MG/125 MG may reduce alertness and cause drowsiness or dizziness. It is advised not to drive if experiencing these symptoms.

pregnancy
C TAZ INJECTION 1000 MG/125 MG is generally safe during pregnancy. Animal studies show minimal harm to the baby, but human studies are limited.

breastfeeding
C TAZ INJECTION 1000 MG/125 MG should be used cautiously while breastfeeding. It is advised to temporarily stop breastfeeding until the mother's treatment is finished and the medicine is cleared from her system.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI INFECTIVES |
Action Class | - |
₹167.76
Inclusive of all taxes
Content verified by

Dr. Preeti Kumar
MBBS, DGO - Obstetrics and Gynaecology, DNB - Obstetrics and Gynaecology
Last update on 01-Oct-2024